In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

The epidemiology of hypertensive response to exercise in a large tertiary referral center in Switzerland

Session Poster session 1

Speaker David Niederseer

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2016

  • Topic : preventive cardiology
  • Sub-topic : Exercise Testing
  • Session type : Poster Session

Authors : D Niederseer (Zurich,CH), A Brauchlin (Zurich,CH), R Baumberger (Zurich,CH), F Baumann (Zurich,CH), CM Schmied (Zurich,CH)

D Niederseer1 , A Brauchlin1 , R Baumberger1 , F Baumann1 , CM Schmied1 , 1University Hospital Zurich, Department of Cardiology - Zurich - Switzerland ,

European Journal of Preventive Cardiology ( September 2016 ) 23 ( Supplement 1 ), S13

Background: Irrespective of apparent ‘normal’ resting blood pressure (BP) in patients without diagnosed arterial hypertension or with optimally treated arterial hypertension, some individuals show an excessive elevation in BP with exercise, a condition termed exercise hypertension or ‘hypertensive response to exercise’ (HRE). HRE is associated with an increased propensity for target organ damage and also predicts the future development of hypertension, cardiovascular events and mortality, independent of resting BP. So far, systolic HRE was reported more often than diastolic or systolic/diastolic (combined) HRE.
Methods: Between January 2009 and May 2012, 2,476 consecutive exercise tests were performed in our institution, a tertiary general cardiology all-comers outpatient clinic. We systematically analyzed all exercise tests with respect to elevated blood pressure at rest (>140/90 mmHg) and at maximal exertion or during the recovery period after exercise (i.e. systolic BP ≥ 210 mmHg in men or ≥ 190 mmHg in women or diastolic BP ≥ 110 mmHg in men or women). Clinical characteristics of all subjects that showed HRE were collected. Results: Of 2,476 exercised patients, 484 (19.5%) patients had elevated BP during exercise (64.0±14.7 years, 70.5% males, coronary artery disease: 48.4%, valvular heart disease: 26.9%, diabetes: 21.9%, BMI 28.1±5.7 kg/m²), of whom 334 (69.0%) had a previously known arterial hypertension. An elevated office blood pressure was found in 172 (35.5% of all patient with elevated BP during exercise) subjects (145 [84.3%] suboptimally treated with known arterial hypertension, 27 [15.7%] previously not diagnosed for arterial hypertension) and therefore did not fulfill the criteria for HRE. The remaining 312 subjects with HRE, that represented 12.6% of all exercise tests subdivided in 189 (60.6%) optimally treated hypertensive patients and 123 (39.4%) subjects without known arterial hypertension. Of all subjects with HRE, 128 had elevated diastolic (5.2% of all exercise tests, 41.0% of all that fulfilled criteria for HRE), 108 (4.3%/34.6%) elevated systolic and 76 (3.1/24.3%) elevated combined (diastolic and systolic) response to exercise. Subjects with diastolic, systolic or combined HRE did not differ with respect to age, gender, body mass index, creatinine clearance, left ventricular ejection fraction; presence of coronary artery disease, valvular heart disease, diabetes, sinus rhythm; or positive family history of arterial hypertension.
Conclusions: In our institution, hypertensive response to exercise was found in 12.6% of all exercise tests. Contrary to previous observations, diastolic HRE was found more often than systolic or combined HRE, and subjects with diastolic, systolic or combined HRE did not differ significantly.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are